Fate therapeutics to host virtual event at the 2020 ash annual meeting

San diego, nov. 30, 2020 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that management will host a virtual event entitled “the power of hncd16” on friday, december 4, 2020 at 4:30 pm edt.
FATE Ratings Summary
FATE Quant Ranking